TTAC-0001

Tanibirumab · PharmAbcine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTAC-0001, covering 2021-01-27 to 2021-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma [Phase 2]